Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 3/2011

01.06.2011 | Original Article

The craniocervical junction following successful haematopoietic stem cell transplantation for mucopolysaccharidosis type I H (Hurler syndrome)

verfasst von: Elke Miebach, Heather Church, Alan Cooper, Jean Mercer, Karen Tylee, Robert F. Wynn, J. Edmond Wraith

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Mucopolysaccharidosis I Hurler (MPS IH) is a progressive multisystemic disorder caused by alpha-L-iduronidase deficiency. First choice of treatment in MPS IH children is haematopoietic stem cell transplantation (HSCT). The effect of HSCT has been shown to have limited influence on skeletal manifestations by poor penetration of musculoskeletal tissues by the enzyme derived from donor leucocytes. Aim of this study was to investigate the effect of HSCT on the craniocervical junction (CCJ) in Hurler patients. We analysed retrospectively sequential magnetic resonance imaging (MRI) scans of 30 patients with Hurler disease treated by HSCT since 1982 at the Royal Manchester Children’s Hospital, UK, in order to determine whether the patients suffer from dens hypoplasia. Results were compared with biochemical and clinical characteristics: Enzyme activity (EA), chimerism, urinary glycosaminoglycan (GAG) excretion and neurological status. Investigations were part of standard clinical procedures. Results are descriptive in presentation. In 26/30 patients a determination of odontoid hypoplasia was feasible. The majority showed a normal dens length and an increase with age. Only 3/26 revealed a dens hypoplasia. One of them had only partial donor engraftment (DE) with reduced EA, one of them suffered from chronic graft versus host disease (GVHD). One patient with only partial DE and reduced EA presented with initial dens hypoplasia until preadolescence but normalized later on. There may be a trend towards lower EA and the occurrence of DH in transplanted MPS patients - perhaps the dosage of enzyme plays a role in the correction of skeletal complications in this patient group. HSCT patients with incomplete DE and therefore lower EAs may require special attention and care.
Literatur
Zurück zum Zitat Aldenhoven M, Boelens JJ, de Koning TJ (2008) The clinical outcome of Hurler syndrome after stem cell transplantation. Biol Blood Marrow Transplant 14:485–498PubMedCrossRef Aldenhoven M, Boelens JJ, de Koning TJ (2008) The clinical outcome of Hurler syndrome after stem cell transplantation. Biol Blood Marrow Transplant 14:485–498PubMedCrossRef
Zurück zum Zitat Cokluk C, Aydin K, Rakunt C, Iyigun O, Onder A (2006) The borders of the odontoid process of C2 in adults and in children including the estimation of odontoid/body ratio. Eur Spine J 15:278–282PubMedCrossRef Cokluk C, Aydin K, Rakunt C, Iyigun O, Onder A (2006) The borders of the odontoid process of C2 in adults and in children including the estimation of odontoid/body ratio. Eur Spine J 15:278–282PubMedCrossRef
Zurück zum Zitat Cox-Brinkman J, Boelens JJ, Wraith JE et al (2006) Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome. Bone Marrow Transplant 38:17–21PubMedCrossRef Cox-Brinkman J, Boelens JJ, Wraith JE et al (2006) Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome. Bone Marrow Transplant 38:17–21PubMedCrossRef
Zurück zum Zitat Elliott S (1988) The odontoid process in children – is it hypoplastic? Clin Radiol 39:391–393PubMedCrossRef Elliott S (1988) The odontoid process in children – is it hypoplastic? Clin Radiol 39:391–393PubMedCrossRef
Zurück zum Zitat Field RE, Buchanan JA, Copplemans MG, Aichroth PM (1994) Bone-marrow transplantation in Hurler’s syndrome effect on skeletal development. J Bone Joint Surg Br 76:975–981PubMed Field RE, Buchanan JA, Copplemans MG, Aichroth PM (1994) Bone-marrow transplantation in Hurler’s syndrome effect on skeletal development. J Bone Joint Surg Br 76:975–981PubMed
Zurück zum Zitat Guffon N, Souillet G, Maire I, Straczek J, Guibaud P (1998) Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr 133:119–125PubMed Guffon N, Souillet G, Maire I, Straczek J, Guibaud P (1998) Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr 133:119–125PubMed
Zurück zum Zitat Hite SH, Peters C, Krivit W (2000) Correction of odontoid dysplasia following bone-marrow transplantation and engraftment (in Hurler syndrome MPS 1H). Pediatr Radiol 30:464–470PubMedCrossRef Hite SH, Peters C, Krivit W (2000) Correction of odontoid dysplasia following bone-marrow transplantation and engraftment (in Hurler syndrome MPS 1H). Pediatr Radiol 30:464–470PubMedCrossRef
Zurück zum Zitat Khanna G, Van Heest AE, Agel J et al (2007) Analysis of factors affecting development of carpal tunnel syndrome in patients with Hurler syndrome after hematopoietic cell transplantation. Bone Marrow Transplant 39:331–334PubMedCrossRef Khanna G, Van Heest AE, Agel J et al (2007) Analysis of factors affecting development of carpal tunnel syndrome in patients with Hurler syndrome after hematopoietic cell transplantation. Bone Marrow Transplant 39:331–334PubMedCrossRef
Zurück zum Zitat Kirks DR (1984) Practical Pediatric Imaging. Little, Brown, Boston Kirks DR (1984) Practical Pediatric Imaging. Little, Brown, Boston
Zurück zum Zitat Malm G, Gustafsson B, Berglund G et al (2008) Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopeietic stem cell transplantation (HSCT). Acta Paediatr 97:1108–1112PubMedCrossRef Malm G, Gustafsson B, Berglund G et al (2008) Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopeietic stem cell transplantation (HSCT). Acta Paediatr 97:1108–1112PubMedCrossRef
Zurück zum Zitat Muenzer J, Wraith JE, Clarke LA (2009) International consensus panel on management and treatment of Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 123:19–29PubMedCrossRef Muenzer J, Wraith JE, Clarke LA (2009) International consensus panel on management and treatment of Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 123:19–29PubMedCrossRef
Zurück zum Zitat Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS et al (eds) The metabolic and molecular bases of inherited diseases. McGraw-Hill, New York, p 3421–3452 Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS et al (eds) The metabolic and molecular bases of inherited diseases. McGraw-Hill, New York, p 3421–3452
Zurück zum Zitat Pastores GM, Arn P, Beck M, Clarke JT et al (2007) The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis type I. Mol Genet Metab 91:37–47PubMedCrossRef Pastores GM, Arn P, Beck M, Clarke JT et al (2007) The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis type I. Mol Genet Metab 91:37–47PubMedCrossRef
Zurück zum Zitat Perovic MN, Kopits SE, Thompson RC (1973) Radiological evaluation of the spinal cord in congenital atlanto-axial dislocation. Radiology 109:713–716PubMed Perovic MN, Kopits SE, Thompson RC (1973) Radiological evaluation of the spinal cord in congenital atlanto-axial dislocation. Radiology 109:713–716PubMed
Zurück zum Zitat Peters C, Steward CG, National Marrow Donor Program; International Bone Marrow Transplant Registry: Working Party on Inborn Errors, European Bone Marrow Transplant Group (2003) Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines. Bone Marrow Transplant 31:229–239PubMedCrossRef Peters C, Steward CG, National Marrow Donor Program; International Bone Marrow Transplant Registry: Working Party on Inborn Errors, European Bone Marrow Transplant Group (2003) Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines. Bone Marrow Transplant 31:229–239PubMedCrossRef
Zurück zum Zitat Skeletal Dysplasia Group (1989) Instability of the upper cervical spine. Arch Dis Child 64:283–288CrossRef Skeletal Dysplasia Group (1989) Instability of the upper cervical spine. Arch Dis Child 64:283–288CrossRef
Zurück zum Zitat Smoker WR, Khanna G (2008) Imaging the craniocervical junction. Child Nerv Syst 24:1123–1145CrossRef Smoker WR, Khanna G (2008) Imaging the craniocervical junction. Child Nerv Syst 24:1123–1145CrossRef
Zurück zum Zitat Staba SL, Escolar ML, Poe M et al (2004) Cord-blood transplants from unrelated donors in patients with Hurler´s syndrome. N Engl J Med 350:1960–1969PubMedCrossRef Staba SL, Escolar ML, Poe M et al (2004) Cord-blood transplants from unrelated donors in patients with Hurler´s syndrome. N Engl J Med 350:1960–1969PubMedCrossRef
Zurück zum Zitat Tandon V, Williamson JB, Cowie RA, Wraith JE (1996) Spinal problems in mucopolysaccharidosis I (Hurler syndrome). J Bone Joint Surg Br 78:938–944PubMedCrossRef Tandon V, Williamson JB, Cowie RA, Wraith JE (1996) Spinal problems in mucopolysaccharidosis I (Hurler syndrome). J Bone Joint Surg Br 78:938–944PubMedCrossRef
Zurück zum Zitat Tsukimura T, Tajima Y, Kawashima I et al (2008) Uptake of a recombinant human alpha-L-iduronidase (Iaroidase) by cultured fibroblasts and osteoblasts. Biol Pharm Bull 31:1691–1965PubMedCrossRef Tsukimura T, Tajima Y, Kawashima I et al (2008) Uptake of a recombinant human alpha-L-iduronidase (Iaroidase) by cultured fibroblasts and osteoblasts. Biol Pharm Bull 31:1691–1965PubMedCrossRef
Zurück zum Zitat Weisstein JS, Delgado E, Steinbach LS, Hart K, Packman S (2004) Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantation. J Pediatr Orthop 24:97–101PubMedCrossRef Weisstein JS, Delgado E, Steinbach LS, Hart K, Packman S (2004) Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantation. J Pediatr Orthop 24:97–101PubMedCrossRef
Metadaten
Titel
The craniocervical junction following successful haematopoietic stem cell transplantation for mucopolysaccharidosis type I H (Hurler syndrome)
verfasst von
Elke Miebach
Heather Church
Alan Cooper
Jean Mercer
Karen Tylee
Robert F. Wynn
J. Edmond Wraith
Publikationsdatum
01.06.2011
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 3/2011
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-011-9309-5

Weitere Artikel der Ausgabe 3/2011

Journal of Inherited Metabolic Disease 3/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.